KJ
Karnik Jashvantlal Shah
About Karnik Jashvantlal Shah
Data last updated:
Karnik Jashvantlal Shah has 7 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Tavion Pharma Llp and Tavion Healthcare Llp. Formerly with 2 companies, such as Shukra Pharmaceuticals Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tavion Pharma Llp AAR-8029 | Designated Partner | 03 Feb 2020 | 2020 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shukra Pharmaceuticals Limited L24231GJ1993PLC019079 | Ceo(Kmp) | 28 May 2019 | 1993 | ₹36.79 Cr (FY 2025) | Active |
| Tavion Healthcare Llp AAR-9888 | Designated Partner | 19 Feb 2020 | 2020 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karnik Jashvantlal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karnik Jashvantlal Shah
Karnik Jashvantlal Shah has 7 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Tavion Pharma Llp and Tavion Healthcare Llp. Formerly with 2 companies, such as Shukra Pharmaceuticals Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Karnik Jashvantlal Shah is associated with 1 company as Designated Partner, including Tavion Pharma Llp.
Karnik Jashvantlal Shah has expertise in General Business, Healthcare.
Karnik Jashvantlal Shah has 7 years in corporate governance.
Karnik Jashvantlal Shah currently holds positions at 1 company: Tavion Pharma Llp.